Products
Reliable supply of quality DPI capsules, backed by logistics validation
We provide fully developed DPI finished dosage forms with and without device options, offering flexibility and scalability for diverse market demands.
- Customized pack sizes: Available in multiple configurations including 15, 30, and 60 capsules per bottle to suit therapy duration and market requirements.
- Combo packs with device: Products can be supplied as a ready-to-use combo pack with a single-use punch inhaler device, ensuring user convenience and compliance.
- Multilingual packaging: All FDFs can be packed with multilingual labeling to meet regional regulatory and patient needs.
- Braille-coded packs: We offer braille-coded packaging to support accessibility and align with international packaging standards.
With Device: Single-use, punch devices, supplied with capsules in bottle, fully assembled and ready for distribution.
Tiotropium
Finished With Device
Your Configuration Summary
Budesonide
Finished With Device
Your Configuration Summary
Formoterol
Finished With Device
Your Configuration Summary
Formoterol-Budesonide
Finished With Device
Your Configuration Summary
Salmeterol-Fluticasone
Finished With Device
Your Configuration Summary
Formoterol-Fluticasone
Finished With Device
Your Configuration Summary
Levosalbutamol-Ipratropium
Finished With Device
Your Configuration Summary
Finished Dose Formuations Without Device
Without Device: DPI formulations filled in bottles — ready for use with compatible inhalation devices.
Tiotropium
Finished Without Device
Your Configuration Summary
Budesonide
Finished Without Device
Your Configuration Summary
Formoterol
Finished Without Device
Your Configuration Summary
Formoterol-Budesonide
Finished Without Device
Your Configuration Summary
Salmeterol-Fluticasone
Finished Without Device
Your Configuration Summary
Formoterol-Fluticasone
Finished Without Device
Your Configuration Summary
Levosalbutamol-Ipratropium
Finished Without Device
Your Configuration Summary
Our DPI FDFs are developed for consistent dosing, high-quality pulmonary delivery, and compliance with global regulatory standards — enabling market readiness.